CLDN11 and vibrio infectious disease: We demonstrate that the vaccine displays V. cholerae OSP in an immunologically relevant manner, is recognized by convalescent phase sera from both Inaba and Ogawa serotype-associated cholera, and induces protective and durable memory immune responses in pre-clinical evaluation studies.